Singapore markets open in 5 hours 6 minutes
Straits Times Index
3,147.39 -44.96 (-1.41%) S&P 500
4,264.81 +35.36 (+0.84%) Dow
33,138.91 +136.53 (+0.41%) Nasdaq
13,240.85 +181.39 (+1.39%) Bitcoin USD
27,668.52 +369.28 (+1.35%) CMC Crypto 200
588.65 +4.49 (+0.77%)
Swedish Orphan Biovitrum AB (B6E.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
As of 11:30AM CEST. Market open.
| Previous close | 18.94 |
| Open | 18.67 |
| Bid | 18.69 x 100000 |
| Ask | 19.04 x 100000 |
| Day's range | 18.67 - 18.83 |
| 52-week range | 16.17 - 23.82 |
| Volume | |
| Avg. volume | 32 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksNurix Therapeutics, Inc. (NRIX) Soars 8.3%: Is Further Upside Left in the Stock?
Nurix Therapeutics, Inc. (NRIX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ZacksIs Swedish Orphan Biovitrum (BIOVF) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
ZacksSwedish Orphan Biovitrum (BIOVF) Beats Q2 Earnings and Revenue Estimates
Swedish Orphan Biovitrum (BIOVF) delivered earnings and revenue surprises of 27.27% and 16.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
© 2023 Yahoo. All rights reserved.
